Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022009248 - A PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE HEADACHES AND A COSOLVENT METHOD OF PREPARATION THEREOF

Publication Number WO/2022/009248
Publication Date 13.01.2022
International Application No. PCT/JO2020/050005
International Filing Date 07.07.2020
IPC
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 9/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
A61K 31/48 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
48Ergoline derivatives, e.g. lysergic acid, ergotamine
A61K 31/4985 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K 47/10 2017.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols ; Poloxamers; PEG/POE alkyl ethers
Applicants
  • JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY [JO]/[JO]
Inventors
  • AL-GHANANEEM, Abeer
Agents
  • THE INTELLECTUAL PROPERTY COMMERCIALIZATION OFFICE/ ROYAL SCIENTIFIC SOCIETY
Priority Data
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) A PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE HEADACHES AND A COSOLVENT METHOD OF PREPARATION THEREOF
(FR) COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DES MIGRAINES ET SON PROCÉDÉ DE PRÉPARATION PAR COSOLVANT
Abstract
(EN) The present disclosure provides a pharmaceutical composition for the treatment of migraines, the pharmaceutical composition comprises dihydroergotamine or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier without the need for caffeine as prservative. The present disclosure further provides a method for producing the pharmaceutical composition.
(FR) La présente invention concerne une composition pharmaceutique pour le traitement des migraines, la composition pharmaceutique comprenant de la dihydroergotamine ou ses sels pharmaceutiquement acceptables, et un support pharmaceutiquement acceptable sans avoir recours à la caféine comme agent de conservation. La présente invention concerne également un procédé de production de la composition pharmaceutique.
Latest bibliographic data on file with the International Bureau